Clinical trial
Effect of Intravenous Lidocaine Infusion on Postoperative Pulmonary Complications in Patients Undergoing Minimally Invasive Esophagectomy: a Double-center, Double-blind, Randomized Controlled Trial
NCT06138041 is registered in ClinicalTrials.gov with Sichuan Cancer Hospital and Research Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Intravenous Lidocaine Infusion on Postoperative Pulmonary Complications in Patients Undergoing Minimally Invasive Esophagectomy: a Double-center, Double-blind, Randomized Controlled Trial
- Lead sponsor
- Sichuan Cancer Hospital and Research Institute
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- February 1, 2025
- Completion date
- August 30, 2025
- Enrollment
- 770 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
postoperative pneumonia, postoperative pulmonary atelectasis, postoperative pulmonary edema